By using our website, you agree to our use of cookies. find out more.
-
Products
Pharmacology
Type
- News
- Custom services
- Ordering
- About Us
- Technical support
- Resources
-
Products
Pharmacology
Type
- News
- Custom services
- Ordering
- About Us
- Technical support
- Resources
Receptor tyrosine kinases
Receptor tyrosine kinases (RTKs) are high-affinity cell surface receptors for many growth factors, cytokines, and hormones. Of the 90 tyrosine kinase genes identified in the human genome, 58 encode receptor tyrosine kinase proteins. All RTKs share a similar protein structure comprised of an extracellular ligand binding domain, a single transmembrane helix, and an intracellular region that contains a juxtamembrane regulatory region, a tyrosine kinase domain and a carboxyl terminal tail. Receptor tyrosine kinases are inactive in the absense of a ligand and are activated by receptor specific ligands binding to extracellular regions of RTKs, which causes receptor dimerization and/or oligomerization, allowing the tyrosine kinase domain to assume an active conformation. Receptor tyrosine kinases play an important role in in mediating and controlling a wide range of complex biological functions, including cell growth, cell-to-cell communication, motility, differentiation, and metabolism. Consequently dysregulation of RTK signaling leads to an assortment of human diseases, including having a critical role in the development and progression of many types of cancer.
Peptides
Cat No. | Product Name | Activity |
---|---|---|
EP-040 | EGFRvIII peptide | EGFRvIII derived epitope |
RT-030 | FGF7p | FGF7 mimetic |
RT-010 | KYL | EphA4 kinase inhibitor |
RT-040 | QK | VEGF mimicking peptide |
RT-020 | TLQP 21 | VGF derived peptide |
Small molecules
Cat No. | Product Name | Activity |
---|---|---|
KS-320 | Staurosporine | Broad spectrum kinase inhibitor |
Further reading
Robinson et al (2000) The protein tyrosine kinase family of the human genome. Oncogene 19(49) 5548 PMID: 11114734
Lemmon and Schlessinger (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7) 1117 PMID: 20602996
Du and Lovly (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17 58 https://doi.org/10.1186/s12943-018-0782-4
Contact Information
To place an order, or for customer services, order processing or technical support please contact us on:
UK, Europe and RoW
Tel: (+44) 01392 422205
Fax: (+44) 01392 279510
info@iscabiochemicals.com
USA and Canada
Tel: 610-994-1134
Toll Free: 855-FOCUS21 (855-362-8721)
Fax: 610-465-9100
France
CliniSciences
Tel : +33 9 77 40 09 09
Fax : +33 9 77 40 10 11
Orders and customer support : info@clinisciences.com
Germany, Switzerland, Austria
BIOZOL Diagnostics
Tel: +49 (089) 3799 666-6
Fax: +49 (089) 3799 666-99
Orders, Technical and Customer support: info@biozol.de
Italy
Labospace
Tel: +39 02 35980841
Fax +39 02 359808004
Orders: info@labospace.com
Spain and Portugal
Abyntek Biopharma
Tel: +34 94 404 80 80
Fax: +34 94 404 80 81
Orders: info@abyntek.com
BIOHUB INTERNATIONAL
上海起发实验试剂有限公司
Tel: +86-15921799099
Tel: +86-021-50724187
Fax: +86-021-50724961
Orders: sale3@78bio.com
India
BTL Biotechno Labs Pvt Ltd
Tel: +91-8860924629
07291852429
Orders, Technical and Customer support: info@biotechnolabs.com
Japan
Namiki Shoji Co.
Tel:+81-050-5527-9850
Fax:+81-3-3352-2196
email: globalbusiness1@namiki-s.co.jp
Recent citations
A new publication from the University of Ljubljana uses MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2, the FRET substrate for the severe acute respiratory syndrome coronavirus main protease (SARS-CoV Mpro), to determine the inhibitory potential of plant polyphenols
Learn moreContact us
Isca Biochemicals
26 Hanover Road
Exeter
EX1 2TL
(+44) 01392 422205
info@iscabiochemicals.com